#BEGIN_DRUGCARD DB03469

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C34H32FeN4O10

# Chemical_IUPAC_Name:
(1R,4S,19R)-10,14-bis(2-carboxyethyl)-4,19-bis(carboxymethyl)-4,9,15,19-tetramethyl-5,20-dioxo-2$l^{5},22$l^{5},23,25-tetraaza-1-ferraoctacyclo[11.9.1.1^{1,8}.1^{3,21}.0^{2,6}.0^{16,23}.0^{18,22}.0^{11,25}]pentacosa-2(6),3(24),7,9,11,13,15,17,21-nonaene-2,22-bis(ylium)

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Heme D

# HET_ID:
DHE

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C34H34N4O10.Fe/c1-15-17(5-7-27(39)40)21-10-22-18(6-8-28(41)42)16(2)20(36-22)11-25-33(3,13-29(43)44)32(48)24(38-25)12-26-34(4,14-30(45)46)31(47)23(37-26)9-19(15)35-21;/h9-12H,5-8,13-14H2,1-4H3,(H6,35,36,37,38,39,40,41,42,43,44,45,46,47,48);/q;+4/p-2/t33-,34+;/m1./s1

# InChI_Key:
InChIKey=LZXRDVBJJHBQJH-VBAOBBRWSA-L

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3469

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
712.484

# Molecular_Weight_Mono:
712.146785397

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1BL9

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
1.21

# Predicted_LogS:
-5.8

# Predicted_Water_Solubility:
1.32e-03 g/l

# Primary_Accession_No:
DB03469

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936687

# PubChem_Substance_ID:
46507660

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01189

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC1=C(CCC(O)=O)C2=CC3=C(CCC(O)=O)C(C)=C4C=C5[N+]6=C(C=C7[N+]8=C(C=C1N2[Fe@]68N34)C(=O)[C@@]7(C)CC(O)=O)C(=O)[C@]5(C)CC(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:17 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Periplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
X16452

# Drug_Target_1_GenBank_ID_Protein:
45358

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
nirS

# Drug_Target_1_Gene_Sequence:
>1707 bp
ATGCCATTTGGCAAGCCACTGGTGGGCACCTTGCTCGCCTCGCTGACGCTGCTGGGCCTG
GCCACCGCTCACGCCAAGGACGACATGAAAGCCGCCGAGCAATACCAGGGTGCCGCTTCC
GCCGTCGATCCCGCTCACGTGGTGCGCACCAACGGCGCTCCCGACATGAGTGAAAGCGAG
TTCAACGAGGCCAAGCAGATCTACTTCCAACGCTGCGCCGGTTGCCACGGCGTCCTGCGC
AAGGGCGCCACCGGCAAGCCGCTGACCCCGGACATCACCCAGCAACGCGGCCAGCAATAC
CTGGAAGCGCTGATCACCTACGGCACCCCGCTGGGCATGCCGAACTGGGGCAGCTCCGGC
GAGCTGAGCAAGGAACAGATCACCCTGATGGCCAAGTACATCCAGCACACCCCGCCGCAA
CCGCCGGAGTGGGGCATGCCGGAGATGCGCGAATCGTGGAAGGTGCTGGTGAAGCCGGAG
GACCGGCCGAAGAAACAGCTCAACGACCTCGACCTGCCCAACCTGTTCTCGGTGACCCTG
CGCGACGCCGGGCAGATCGCCCTGGTCGACGGCGACAGCAAAAAGATCGTCAAGGTCATC
GATACCGGCTATGCCGTGCATATCTCGCGGATGTCCGCTTCCGGCCGCTACCTGCTGGTG
ATCGGCCGCGACGCGCGGATCGACATGATCGACCTGTGGGCCAAGGAGCCGACCAAGGTC
GCCGAGATCAAGATCGGCATCGAGGCGCGCTCGGTGGAAAGCTCCAAGTTCAAGGGCTAC
GAGGACCGCTACACCATCGCCGGCGCCTACTGGCCGCCGCAGTTCGCGATCATGGACGGC
GAGACCCTGGAACCGAAGCAGATCGTCTCCACCCGCGGCATGACCGTAGACACCCAGACC
TACCACCCGGAACCGCGCGTGGCGGCGATCATCGCCTCCCACGAGCACCCCGAGTTCATC
GTCAACGTGAAGGAGACCGGCAAGGTCCTGCTGGTCAACTACAAGGATATCGACAACCTC
ACCGTCACCAGCATCGGTGCGGCGCCGTTCCTCCACGACGGCGGCTGGGACAGCAGCCAC
CGCTACTTCATGACCGCCGCCAACAACTCCAACAAGGTTGCCGTGATCGACTCCAAGGAC
CGTCGCCTGTCGGCCCTGGTCGACGTCGGCAAGACCCCGCACCCGGGGCGTGGCGCCAAC
TTCGTGCATCCCAAGTACGGCCCGGTGTGGAGCACCAGCCACCTGGGCGACGGCAGCATC
TCGCTGATCGGCACCGATCCGAAGAACCATCCGCAGTACGCCTGGAAGAAAGTCGCCGAA
CTACAGGGCCAGGGCGGCGGCTCGCTGTTCATCAAGACCCATCCGAAGTCCTCGCACCTC
TACGTCGACACCACCTTCAACCCCGACGCCAGGATCAGCCAGAGCGTCGCGGTGTTCGAC
CTGAAGAACCTCGACGCCAAGTACCAGGTGCTGCCGATCGCCGAATGGGCCGATCTCGGC
GAAGGCGCCAAGCGGGTGGTGCAGCCCGAGTACAACAAGCGCGGCGATGAAGTCTGGTTC
TCGGTGTGGAACGGCAAGAACGACAGCTCCGCGCTGGTGGTGGTGGACGACAAGACCCTG
AAGCTCAAGGCCGTGGTCAAGGACCCGCGGCTGATCACCCCGACCGGTAAGTTCAACGTC
TACAACACCCAGCACGACGTGTACTGA

# Drug_Target_1_General_Function:
Energy production and conversion

# Drug_Target_1_General_References:
10329702	Nurizzo D, Cutruzzola F, Arese M, Bourgeois D, Brunori M, Cambillau C, Tegoni M: Does the reduction of c heme trigger the conformational change of crystalline nitrite reductase? J Biol Chem. 1999 May 21;274(21):14997-5004.
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.
11226222	Cutruzzola F, Brown K, Wilson EK, Bellelli A, Arese M, Tegoni M, Cambillau C, Brunori M: The nitrite reductase from Pseudomonas aeruginosa: essential role of two active-site histidines in the catalytic and structural properties. Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2232-7.
11563915	Brown K, Roig-Zamboni V, Cutruzzola' F, Arese M, Sun W, Brunori M, Cambillau C, Tegoni M: Domain swing upon His to Ala mutation in nitrite reductase of Pseudomonas aeruginosa. J Mol Biol. 2001 Sep 21;312(3):541-54.
2152881	Nordling M, Young S, Karlsson BG, Lundberg LG: The structural gene for cytochrome c551 from Pseudomonas aeruginosa. The nucleotide sequence shows a location downstream of the nitrite reductase gene. FEBS Lett. 1990 Jan 1;259(2):230-2.
2155133	Arai H, Sanbongi Y, Igarashi Y, Kodama T: Cloning and sequencing of the gene encoding cytochrome c-551 from Pseudomonas aeruginosa. FEBS Lett. 1990 Feb 12;261(1):196-8.
2506077	Silvestrini MC, Galeotti CL, Gervais M, Schinina E, Barra D, Bossa F, Brunori M: Nitrite reductase from Pseudomonas aeruginosa: sequence of the gene and the protein. FEBS Lett. 1989 Aug 28;254(1-2):33-8.
9331415	Nurizzo D, Silvestrini MC, Mathieu M, Cutruzzola F, Bourgeois D, Fulop V, Hajdu J, Brunori M, Tegoni M, Cambillau C: N-terminal arm exchange is observed in the 2.15 A crystal structure of oxidized nitrite reductase from Pseudomonas aeruginosa. Structure. 1997 Sep 15;5(9):1157-71.
9760233	Nurizzo D, Cutruzzola F, Arese M, Bourgeois D, Brunori M, Cambillau C, Tegoni M: Conformational changes occurring upon reduction and NO binding in nitrite reductase from Pseudomonas aeruginosa. Biochemistry. 1998 Oct 6;37(40):13987-96.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3127

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
62654

# Drug_Target_1_Name:
Nitrite reductase

# Drug_Target_1_Number_of_Residues:
568

# Drug_Target_1_PDB_ID:
1GJQ

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00034	Cytochrom_C
PF02239	Cytochrom_D1

# Drug_Target_1_Protein_Sequence:
>Nitrite reductase precursor
MPFGKPLVGTLLASLTLLGLATAHAKDDMKAAEQYQGAASAVDPAHVVRTNGAPDMSESE
FNEAKQIYFQRCAGCHGVLRKGATGKPLTPDITQQRGQQYLEALITYGTPLGMPNWGSSG
ELSKEQITLMAKYIQHTPPQPPEWGMPEMRESWKVLVKPEDRPKKQLNDLDLPNLFSVTL
RDAGQIALVDGDSKKIVKVIDTGYAVHISRMSASGRYLLVIGRDARIDMIDLWAKEPTKV
AEIKIGIEARSVESSKFKGYEDRYTIAGAYWPPQFAIMDGETLEPKQIVSTRGMTVDTQT
YHPEPRVAAIIASHEHPEFIVNVKETGKVLLVNYKDIDNLTVTSIGAAPFLHDGGWDSSH
RYFMTAANNSNKVAVIDSKDRRLSALVDVGKTPHPGRGANFVHPKYGPVWSTSHLGDGSI
SLIGTDPKNHPQYAWKKVAELQGQGGGSLFIKTHPKSSHLYVDTTFNPDARISQSVAVFD
LKNLDAKYQVLPIAEWADLGEGAKRVVQPEYNKRGDEVWFSVWNGKNDSSALVVVDDKTL
KLKAVVKDPRLITPTGKFNVYNTQHDVY

# Drug_Target_1_Reaction:
nitric oxide + H2O + ferricytochrome c = nitrite + ferrocytochrome c + 2 H+

# Drug_Target_1_Signals:
1-25

# Drug_Target_1_Specific_Function:
Nitric oxide + H(2)O + ferricytochrome c = nitrite + ferrocytochrome c + 2 H(+)

# Drug_Target_1_SwissProt_ID:
P24474

# Drug_Target_1_SwissProt_Name:
NIRS_PSEAE

# Drug_Target_1_Synonyms:
Cytochrome cd1
Cytochrome oxidase
EC 1.7.2.1
EC 1.7.99.1
Hydroxylamine reductase
Nitrite reductase precursor

# Drug_Target_1_Theoretical_pI:
8.21

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Periplasm

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
U75413

# Drug_Target_2_GenBank_ID_Protein:
1654415

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
nirS

# Drug_Target_2_Gene_Sequence:
>1791 bp
ATGAGACAAAGGACTCCATTCGCCAGACCCGGCCTCCTGGCCTCGGCAGCCCTGGCCCTT
GTCCTTGGACCGCTTGCGGCCGCGGCACAGGAACAGGTCGCCCCGCCAAAGGATCCAGCC
GCCGCGCTGGAGGACCACAAGACGCGCACCGACAATCGCTATGAGCCCTCGCTGGACAAC
CTTGCGCAGCAGGATGTCGCGGCTCCCGGGGCCCCCGAGGGTGTCACGGCCCTGTCCGAT
GCCCAATACAACGAGGCCAACAAGATCTATTTCGAACGCTGCGCCGGCTGCCACGGCGTG
TTGCGCAAAGGCGCGACCGGCAAGGCGCTGACCCCTGACCTGACCCGCGATCTGGGCTTT
GACTACCTGCAAAGCTTCATCACCTACGCCTCGCCGGCGGGGATGCCGAACTGGGGCACC
TCGGGCGAGTTGTCGGCCGAGCAGGTCGACCTGATGGCCAACTACCTGCTTCTGGACCCG
GCCGCGCCGCCGGAATTCGGCATGAAGGAGATGCGCGAATCCTGGAAGGTGCATGTCGCG
CCGGAAGACCGGCCGACCCAGCAGGAAAACGACTGGGATCTGGAAAACCTGTTCAGCGTC
ACCCTGCGCGACGCCGGCCAGATCGCGCTGATCGACGGCACCACCTATGAGATCAAGTCG
GTCCTCGACACCGGCTATGCGGTCCATATCAGCCGGCTGTCCGCATCGGGCCGCTACCTG
TTCGTGATCGGCCGCGACGGCAAGGTCAACATGATCGACCTGTGGATGAAGGAGCCCACC
ACCGTTGCCGAGATCAAGATCGGCTCGGAGGCGCGTTCCATCGAGACCTCGAAGATGGAG
GGCTGGGAGGACAAATACGCCATCGCCGGGGCCTATTGGCCGCCGCAATACGTCATCATG
GACGGCGAGACGCTGGAGCCGAAAAAGATCCAGTCCACGCGCGGCATGACCTATGACGAG
CAGGAATATCACCCCGAGCCGCGCGTCGCCGCGATCCTCGCCAGCCATTACCGGCCCGAG
TTCATCGTGAACGTCAAGGAAACGGGCAAGATCCTGCTGGTCGACTATACCGACCTCGAC
AACCTCAAGACCACCGAGATCAGCGCCGAACGCTTCCTGCACGACGGCGGCCTGGACGGC
TCGCACCGCTATTTCATCACCGCGGCGAACGCCCGCAACAAGCTGGTGGTGATCGACACC
AAGGAAGGCAAGCTGGTCGCGATCGAGGATACCGGCGGCCAGACCCCGCATCCGGGCCGC
GGCGCGAACTTCGTCCACCCGACCTTCGGGCCGGTCTGGGCGACCTCGCATATGGGCGAC
GATTCGGTGGCGCTGATCGGCACCGATCCCGAGGGCCATCCCGACAATGCCTGGAAGATC
CTCGACAGCTTCCCGGCGTTGGGGGGCGGCTCGCTGTTCATCAAGACGCACCCGAACTCG
CAATATCTCTATGTCGATGCGACCCTGAACCCCGAGGCCGAGATTTCCGGCTCGGTCGCG
GTGTTCGACATCAAGGCGATGACGGGCGACGGTTCGGACCCCGAGTTCAAGACCCTGCCC
ATCGCCGAATGGGCCGGCATCACCGAAGGCCAGCCCCGCGTCGTGCAGGGCGAGTTCAAC
AAGGACGGCACCGAGGTCTGGTTCAGCGTCTGGAACGGCAAGGACCAGGAATCGGCGCTG
GTCGTGGTGGACGACAAGACGCTGGAACTTAAGCACGTCATCAAGGACGAGCGGCTGGTG
ACGCCCACCGGCAAGTTCAACGTCTACAACACCATGACCGACACCTATTGA

# Drug_Target_2_General_Function:
Energy production and conversion

# Drug_Target_2_General_References:
10708389	Saunders NF, Ferguson SJ, Baker SC: Transcriptional analysis of the nirS gene, encoding cytochrome cd1 nitrite reductase, of Paracoccus pantotrophus LMD 92.63. Microbiology. 2000 Feb;146 ( Pt 2):509-16.
10827177	Jafferji A, Allen JW, Ferguson SJ, Fulop V: X-ray crystallographic study of cyanide binding provides insights into the structure-function relationship for cytochrome cd1 nitrite reductase from Paracoccus pantotrophus. J Biol Chem. 2000 Aug 18;275(33):25089-94.
10998233	Sjogren T, Svensson-Ek M, Hajdu J, Brzezinski P: Proton-coupled structural changes upon binding of carbon monoxide to cytochrome cd1: a combined flash photolysis and X-ray crystallography study. Biochemistry. 2000 Sep 12;39(36):10967-74.
11237728	Gordon EH, Steensma E, Ferguson SJ: The cytochrome c domain of dimeric cytochrome cd(1) of Paracoccus pantotrophus can be produced at high levels as a monomeric holoprotein using an improved c-type cytochrome expression system in Escherichia coli. Biochem Biophys Res Commun. 2001 Mar 2;281(3):788-94.
11278884	Sjogren T, Hajdu J: Structure of the bound dioxygen species in the cytochrome oxidase reaction of cytochrome cd1 nitrite reductase. J Biol Chem. 2001 Apr 20;276(16):13072-6. Epub 2001 Jan 26.
11373294	Sjogren T, Hajdu J: The Structure of an alternative form of Paracoccus pantotrophus cytochrome cd(1) nitrite reductase. J Biol Chem. 2001 Aug 3;276(31):29450-5. Epub 2001 May 23.
7736589	Fulop V, Moir JW, Ferguson SJ, Hajdu J: The anatomy of a bifunctional enzyme: structural basis for reduction of oxygen to water and synthesis of nitric oxide by cytochrome cd1. Cell. 1995 May 5;81(3):369-77.
9199411	Baker SC, Saunders NF, Willis AC, Ferguson SJ, Hajdu J, Fulop V: Cytochrome cd1 structure: unusual haem environments in a nitrite reductase and analysis of factors contributing to beta-propeller folds. J Mol Biol. 1997 Jun 13;269(3):440-55.
9311786	Williams PA, Fulop V, Garman EF, Saunders NF, Ferguson SJ, Hajdu J: Haem-ligand switching during catalysis in crystals of a nitrogen-cycle enzyme. Nature. 1997 Sep 25;389(6649):406-12.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
3284

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
65384

# Drug_Target_2_Name:
Nitrite reductase

# Drug_Target_2_Number_of_Residues:
596

# Drug_Target_2_PDB_ID:
1HCM

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00034	Cytochrom_C
PF02239	Cytochrom_D1

# Drug_Target_2_Protein_Sequence:
>Nitrite reductase precursor
MRQRTPFARPGLLASAALALVLGPLAASAQEQVAPPKDPAAALEDHKTRTDNRYEPSLDN
LAQQDVAAPGAPEGVSALSDAQYNEANKIYFERCAGCHGVLRKGATGKALTPDLTRDLGF
DYLQSFITYGSPAGMPNWGTSGELSAEQVDLMANYLLLDPAAPPEFGMKEMRESWKVHVA
PEDRPTQQENDWDLENLFSVTLRDAGQIALIDGATYEIKSVLDTGYAVHISRLSASGRYL
FVIGRDGKVNMIDLWMKEPTTVAEIKIGSEARSIETSKMEGWEDKYAIAGAYWPPQYVIM
DGETLEPKKIQSTRGMTYDEQEYHPEPRVAAILASHYRPEFIVNVKETGKILLVDYTDLD
NLKTTEISAERFLHDGGLDGSHRYFITAANARNKLVVIDTKEGKLVAIEDTGGQTPHPGR
GANFVHPTFGPVWATSHMGDDSVALIGTDPEGHPDNAWKILDSFPALGGGSLFIKTHPNS
QYLYVDATLNPEAEISGSVAVFDIKAMTGDGSDPEFKTLPIAEWAGITEGQPRVVQGEFN
KDGTEVWFSVWNGKDQESALVVVDDKTLELKHVIKDERLVTPTGKFNVYNTMTDTY

# Drug_Target_2_Reaction:
nitric oxide + H2O + ferricytochrome c = nitrite + ferrocytochrome c + 2 H+

# Drug_Target_2_Signals:
1-29

# Drug_Target_2_Specific_Function:
Nitric oxide + H(2)O + ferricytochrome c = nitrite + ferrocytochrome c + 2 H(+)

# Drug_Target_2_SwissProt_ID:
P72181

# Drug_Target_2_SwissProt_Name:
NIRS_PARPN

# Drug_Target_2_Synonyms:
Cytochrome cd1
Cytochrome oxidase
EC 1.7.2.1
EC 1.7.99.1
Hydroxylamine reductase
Nitrite reductase precursor

# Drug_Target_2_Theoretical_pI:
4.59

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB03469
